Signature-aware deep learning reveals distinct driver gene programs and mutational processes in glioblastoma and colon adenocarcinoma
- 26 February 2026
- journal article
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 123, 108984
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Treatment advances across the cervical cancer spectrumNature Reviews Clinical Oncology, 2025
- Therapeutic and prognostic insights from the analysis of cancer mutational signaturesTrends in Genetics, 2021
- Analysis of mutational signatures with yet another package for signature analysisGenes, Chromosomes and Cancer, 2020
- Pan-cancer analysis of whole genomesNature, 2020
- The repertoire of mutational signatures in human cancerNature, 2020
- Universal Patterns of Selection in Cancer and Somatic TissuesCell, 2017
- Predicting effects of noncoding variants with deep learning–based sequence modelNature Methods, 2015
- Functional annotation of noncoding sequence variantsNature Methods, 2014
- Mutational heterogeneity in cancer and the search for new cancer-associated genesNature, 2013
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012